Market cap
$1,140 Mln
Revenue (TTM)
$478 Mln
P/E Ratio
86.7
P/B Ratio
2.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$13 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
46.09
-
EV/EBITDA
21.9
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$0.4
-
Face value
--
-
Shares outstanding
34,582,900
10 Years Aggregate
CFO
$419.10 Mln
EBITDA
$368.50 Mln
Net Profit
$77.42 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Natus Medical (NTUS)
| 38.9 | 6.0 | -1.4 | 34.5 | 7.9 | -3.4 | 9.8 |
|
BSE Sensex*
| -10.1 | -3.6 | 2.5 | -5.7 | 4.9 | 5.5 | 10.1 |
|
Company
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|---|---|---|---|---|---|---|---|
|
Natus Medical (NTUS)
| 18.4 | -39.3 | -3.1 | -10.9 | 9.8 | -27.6 | 33.3 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Natus Medical (NTUS)
|
33.0 | 1,139.9 | 478.3 | 12.7 | 4.4 | 2.4 | 86.7 | 2.6 |
| 62.7 | 8,162.7 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.0 | |
| 15.0 | 10,125.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.8 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.4 | |
| 58.5 | 8,913.0 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 177.5 | 10,637.8 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 15.3 | |
| 101.0 | 6,590.6 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.2 | 5.0 | |
| 322.2 | 12,649.5 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.3 | 8.3 | |
| 167.6 | 9,458.6 | 785.1 | 41.5 | 9.9 | 2 | 232.8 | 4.6 | |
| 28.9 | 12,007.0 | 6,164.0 | 625.0 | 13.0 | 11.8 | 19.5 | 2.3 |
Shareholding Pattern
View DetailsAbout Natus Medical (NTUS)
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection,... treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin. Read more
-
Pres, CEO & Director
Mr. Thomas Joseph Sullivan
-
Pres, CEO & Director
Mr. Thomas Joseph Sullivan
-
Headquarters
Middleton, WI
-
Website
FAQs for Natus Medical (NTUS)
What is the current share price of Natus Medical Incorporated (NTUS) Today?
The share price of Natus Medical Incorporated (NTUS) is $32.96 (NASDAQ) as of 21-Jul-2022 09:30 EDT. Natus Medical Incorporated (NTUS) has given a return of 7.88% in the last 3 years.
What is the current PB & PE ratio of Natus Medical Incorporated (NTUS)?
The P/E ratio of Natus Medical Incorporated (NTUS) is 86.74 times as on 21-Jul-2022, a 88 premium to its peers’ median range of 46.09 times.
The P/B ratio of Natus Medical Incorporated (NTUS) is 2.65 times as on 21-Jul-2022, a 30 discount to its peers’ median range of 3.78 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
61.23 |
1.90 |
2020 |
-41.01 |
1.66 |
2019 |
-71.58 |
2.70 |
2018 |
-48.96 |
2.82 |
2017 |
-62.12 |
2.99 |
What is the 52 Week High and Low of Natus Medical Incorporated (NTUS)?
The 52-week high and low of Natus Medical Incorporated (NTUS) are Rs -- and Rs -- as of 08-Sep-2026.
What is the market cap of Natus Medical Incorporated (NTUS)?
Natus Medical Incorporated (NTUS) has a market capitalisation of $ 1,140 Mln as on 21-Jul-2022. As per SEBI classification, it is a company.
Should I invest in Natus Medical Incorporated (NTUS)?
Before investing in Natus Medical Incorporated (NTUS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.